Fujifilm Healthcare Finalizes Acquisition of Hitachi’s Imaging Business


By: Randolph Fillmore

Doctors look over x-ray results, an example of diagnostics imaging.

FujiFilm Corporation announced that the acquisition of Hitachi’s diagnostic imaging business for $1.6 billon has been completed. Fujifilm Healthcare will now begin operating as Fujifilm Group Company.

The acquisition was originally announced in December 2019, but the COVID-19 pandemic delayed the acquisition several times.

Fugifilm will further expand its medical systems business and will “amass its technologies, products and services to provide extensive solutions of even greater quality, thereby contributing to improving the quality of medical care and maintaining and promoting peoples’ health,” the company wrote, adding that the acquisition gives the Fugifilm Group a “comprehensive product lineup covering CT, MRI, X-ray, ultrasound systems, endoscopy, in-vitro diagnostic systems and PACS.”

In the future, the products are intended to be combined with Fujifilm’s image processing and AI technology “to create even higher value-added solutions based on medical IT, to be provided globally.”